Mable (private company)
See something wrong or missing? Let us know
Offices:Oxford
Industry:BiotechHealth servicesPharma
Business model:B2B
Mable (formerly Neurolytic Healthcare) provides personalized medicine for neurological conditions, as it collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.
values in USD
Investments 3.33M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Mable
Name | Criteria | |
---|---|---|
![]() |
PEP-Therapy
77%
|
|
![]() |
Octarine Bio
75%
|
|
![]() |
Causaly
75%
|
|
![]() |
Kither Biotech
75%
|
|
![]() |
Relation Therapeutics
75%
|
|
![]() |
Cinclus Pharma
72%
|
|
![]() |
SolasCure
72%
|
|
![]() |
Pila Pharma
70%
|
|
![]() |
Atley Solutions
70%
|
|
![]() |
Vaxxel
70%
|
|